Related Experiment Videos
Surgical resection for isolated cardiac metastases
Archives of Surgery (Chicago, Ill. : 1960)
|January 1, 1983
Summary
Surgical resection of heart metastases from liposarcoma is feasible. Aggressive surgical therapy can lead to successful outcomes for patients with controlled primary tumors and long disease-free intervals.
Area of Science:
- Cardiovascular Surgery
- Surgical Oncology
- Medical Imaging
Background:
- Metastatic disease to the heart is rare but associated with poor prognosis.
- Surgical resection of cardiac metastases is an option for select patients.
- Liposarcoma is a malignant mesenchymal tumor for which cardiac metastasis is an uncommon presentation.
Observation:
- The study reports the second successful resection of metastatic liposarcoma to the heart.
- Previous analyses of cardiac metastasis resections (n=10) showed survival ranging from 4 months to 2 years.
- Computed tomographic (CT) scans of the chest aided in diagnosis and tumor extent delineation.
Findings:
- Successful resection of solitary cardiac metastases is achievable in patients who can tolerate major surgery.
- Favorable outcomes are linked to effective control of the primary tumor.
- Patients with sarcomas and extended disease-free intervals may benefit from aggressive surgical intervention.
Implications:
- Aggressive surgical management, including cardiopulmonary bypass, can be a viable treatment for cardiac liposarcoma metastases.
- Early and accurate diagnosis using CT imaging is crucial for surgical planning.
- This approach offers a potential survival benefit for carefully selected patients with advanced sarcomas.